紫罗酮和麦角固醇对酵母生长及产辅酶Q10的影响

研究了β-紫罗酮和麦角固醇对酵母生长及产辅酶Q₁₀的影响。研究发现,β-紫罗酮能促进菌体积累辅酶Q₁₀,当培养基中β-紫罗酮的添加量为0.208×10^-3mol/L时,菌体中CoQ₁₀的含量提高了28.3%;少量麦角固醇能促进菌体产辅酶Q₁₀,当麦角固醇的添加量为0.15×10^-4mol/L时,菌体中CoQ₁₀的含量提高了31.8%,而增加麦角固醇的添加     

产辅酶Q10酵母的发酵条件研究

研究了豆油、豆粉、胡萝卜汁、西红柿汁、烟叶、β-胡萝卜素、桔子皮汁等自然物的添加对酵母发酵生产CoQ10的影响,结果表明它们均能大幅度提高酵母菌中CoQ10的含量。其中豆油、豆粉、西红柿汁、桔子皮汁是富含CoQ10。和胡萝卜素合成途经中的前体物质因而提高了CoQ10的产量;烟叶和β-胡萝卜素阻断了合成β-胡萝卜素的途经从而起到提高CoQ10合成的作用;胡萝卜汁的作用可能两兼而有之。因此可以得出以下结论,微生物中Co10的合成与β-胡萝卜素的合成密切相关。     

微生物发酵生产辅酶Q10的研究进展

利用微生物发酵生产辅酶Q1 0 产物活性好 ,并可通过规模放大提高生产能力 ,因而颇受国内外学者的关注。文章综述菌种的选择和遗传改造 ,发酵条件的优化及其分离纯化     

酵母发酵生产辅酶Q10提取方法研究进展

辅酶Q10是存在于哺乳动物中,能与酶蛋白形成复合物以发挥酶学活性的有机小分子化合物,目前广泛应用于医药、日化、保健、食品等不同领域。辅酶Q10来源丰富,其中酵母是其工业生产的主要来源之一。广受关注的酵母发酵生产辅酶Q10的提取分离手段不断革新,产量不断增加,处理方式更加环保,应用日渐拓宽。本文就近年来国内外酵母发酵生产辅酶Q10的提取分离方法进行了综述,包括酵母菌种的类型与优化、辅酶Q10提取检测方法、工业生产放大工艺以及与产品质量相关的各个影响因素,并对酵母发酵生产辅酶Q10的前景进行了展望。     

光合细菌产辅酶Q10发酵条件的研究

利用均匀设计原理进行实验设计 ,对光合细菌R .capsulatusMT1131产辅酶Q10培养基配方及培养条件进行优化 ,结果当培养基中酵母膏质量浓度为 3 .13g·L- 1 ,硫酸铵 0 .8g·L- 1 ,Mg2 + 0 .6 4g·L- 1 ,Fe2 + 45 .2mg·L- 1 ,Mn2 + 18mg·L- 1 ,Co2 + 16mg·L- 1 ,培养基初始pH值为 7.0时 ,于 30℃ ,光照强度为 2 0 0 0Lx条件下培养 4天后 ,菌体中辅酶Q10质量浓度由 15 .2 13mg·L- 1提高至 2 0 .36 5mg·L- 1 ,产量提高约 33.87%。     

促进剂对发酵生产辅酶Q10的影响

研究了几种促进剂对放射型根瘤菌细胞生长及其辅酶Q10发酵的影响。结果表明:在培养基中适量添加VB1、乙酸钠、花生油均可明显提高辅酶Q10的产量,使用正交试验优化后的促进剂组合可使辅酶Q10产量达到50.7 mg/L,比对照组提高33%。     

辅酶Q10的生理作用及临床应用

辅酶Q10是线粒体电子传递链中的一种重要辅酶,参与细胞氧化磷酸化及ATP生成过程。辅酶Q10是细胞代谢呼吸激活剂和免疫增强剂,具有抗氧化和自由基清除功能。辅酶Q10药物的临床应用主要在心血管疾病、高血压、神经系统疾病和免疫系统疾病方面。     

微生物发酵产辅酶Q10的高速逆流色谱法分离纯化

本文首次将高速逆流色谱法应用于微生物发酵液提取物中辅酶Q10的分离纯化,建立了一套可用于其制备分离的逆流色谱溶剂体系正庚烷－乙睛－二氯甲烷(12：7：3.5, v/v/v)。500mg发酵液粗提物经一步制备分离,可得到绝对纯度在98％以上辅酶Q10130mg。比较表明,该方法较传统的硅胶柱层析和结晶相结合的纯化方法在产物纯度、回收率及产率等方面都有一定的优势。     

代谢工程改造大肠杆菌生产辅酶Q10

辅酶Q10(CoQ10)是一种脂溶性抗氧化剂,具有提高人体免疫力、延缓衰老和增强人体活力等功能,广泛应用于制药行业和化妆品行业。微生物发酵法能可持续性生产辅酶Q10,具有越来越多的商业价值。本研究首先将来自类球红细菌的十聚异戊二烯焦磷酸合成酶基因(dps)整合到大肠杆菌ATCC 8739染色体上,敲除内源的八聚异戊二烯焦磷酸合成酶基因(ispB),使内源的辅酶Q8合成途径被辅酶Q10合成途径取代,得到稳定生产辅酶Q10的菌株GD-14,其辅酶Q10产量达0.68 mg/L,单位细胞含量达0.54 mg/g DCW。随后用多个固定强度调控元件在染色体上对MEP途径的关键基因dxs和idi基因以及ubiCA基因进行组合调控,将辅酶Q10单位细胞含量提高2.46倍(从0.54到1.87 mg/g)。进一步引入运动发酵单胞菌Zymomonas mobilis的Glf转运蛋白代替自身的磷酸烯醇式丙酮酸:碳水化合物磷酸转移酶系统(PTS),使辅酶Q10产量进一步提高16%。最后,对高产菌株GD-51进行分批补料发酵,辅酶Q10产量达433 mg/L,单位细胞含量达11.7 mg/g DCW。这是目前为止文献报道的大肠杆菌产辅酶Q10最高菌株。     

辅酶Q10的生物合成及其高表达研究进展

辅酶Q10(CoQ10)不仅是呼吸链上的电子传递体,同时也具有抗氧化功能。目前全球市场上的CoQ10正处于一种供不应求的状态。我们简要论述了CoQ10的结构、性质、功能及其生物合成过程,同时概括总结了现阶段为提高CoQ10产量而采用的新型技术手段。     

Influence of Aldicarb on the Growth and Yield of Tobacco

Microplot and field experiments were used to examine the plant-growth stimulation frequently associated with the use of aldicarb on tobacco in the absence of major pests. Aldicarb rates of 1.5-4.5 kg a.i./ha enhanced tobacco growth and yield in most experiments, but higher rates (≥ 4.5 kg) usually resulted in a neutral to negative effect. Tobacco cultivars NC 82 and Speight G-28 were more responsive than McNair 944 to the pesticide in microplots. Supplemental irrigation enhanced the responsiveness of Speight G-70 tobacco and McNair 944 to aldicarb, but excessive moisture (ca. 7-8 cm/week) limited cured-leaf yields. Aldicarb also resulted in the greatest mean tobacco yields in 35 field experiments involving Meloidogyne spp. over 3 years, relative to ethoprop, 1,3-dichloropropene (1,3-D), 1,3-D + chloropicrin, and nontreated controls. Thus, aldicarb generally enhanced tobacco growth and yield in the presence or absence of nematodes, but its impact is dependent on other variables, including cultivar, soil moisture, and soil type.     

CoQ10 supplementation elevates the epidermal CoQ10 level in adult hairless mice

We have already shown that prolonged supplementation of CoQ(10) in humans reduces the wrinkle area rate and wrinkle volume per unit area in the corner of the eye. CoQ(10) supplementation is known to increase the CoQ(10) level in serum and in many organs; however, the level of CoQ(10) in skin has not yet been fully investigated yet. We examined whether CoQ(10) intake elevates the CoQ(10) and CoQ(9) levels in epidermis, dermis, serum and other organs (kidney, heart, brain, muscle and crystalline lens) in 43-week-old hairless male mice. We also established a method using a high performance liquid chromatograph equipped with an electrochemical detector (HPLC-ECD) to simultaneously quantify CoQ(9) and CoQ(10) in the tissues. CoQ(10) (0, 1, 100 mg/kg p.o.) was administered daily for 2 weeks. CoQ(10) supplementation of 100 mg/kg increased the serum and epidermal CoQ(10) levels significantly, but did not increase the CoQ(10) levels in either dermis or other organs. In conclusion, we showed that CoQ(10) intake elevates the epidermal CoQ(10) level, which may be a prerequisite to the reduction of wrinkles and other benefits related to the potent antioxidant and energizing effects of CoQ(10) in skin.     

Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism

Coenzyme Q₁₀ (CoQ₁₀) is a promising agent for neuroprotection in neurodegenerative diseases. We tested the effects of various doses of two formulations of CoQ₁₀ in food and found that administration in the diet resulted in significant protection against loss of dopamine (DA), which was accompanied by a marked increase in plasma concentrations of CoQ₁₀. We further investigated the neuroprotective effects of CoQ₁₀, reduced CoQ₁₀ (ubiquinol), and CoQ₁₀ emulsions in the (MPTP) model of Parkinson's disease (PD). We found neuroprotection against MPTP induced loss of DA using both CoQ₁₀, and reduced CoQ₁₀, which produced the largest increases in plasma concentrations. Lastly, we administered CoQ₁₀ in the diet to test its effects in a chronic MPTP model induced by administration of MPTP by Alzet pump for 1 month. We found neuroprotective effects against DA depletion, loss of tyrosine hydroxylase neurons and induction of alpha-synuclein inclusions in the substantia nigra pars compacta. The finding that CoQ₁₀ is effective in a chronic dosing model of MPTP toxicity, is of particular interest, as this may be more relevant to PD. These results provide further evidence that administration of CoQ₁₀ is a promising therapeutic strategy for the treatment of PD.     

酵母菌产麦角固醇发酵条件的研究

为了提高酵母菌麦角固醇的产量,采用摇瓶培养法,对筛选出的一株酵母菌YN2产麦角固醇发酵条件进行了研究。结果表明,酵母菌YN2产麦角固醇适宜的培养基配方为：酵母粉1％,牛肉膏2．5％,葡萄糖8％,K2HPO4 0．3％,MgSO4 0．15％,该菌株产麦角固醇最适培养条件为：培养温度28℃,起始pH6．5,发酵时间72h。在优化的实验条件下,麦角固醇含量可达2．2％,100ml发酵液中麦角固醇产量达25．30mg。     

甾醇酰基转移酶基因高表达对酵母菌麦角甾醇合成的影响

通过PCR扩增克隆到含酵母菌甾醇酰基转移酶基因ARE2编码序列和上游调控序列的DNA片段ARE21及仅含编码序列的DNA片段ARE22。分别以ARE2启动子,乙醇脱氢酶基因ADH1启动子和铜抗性基因CUP1启动子及ADH1终止子为调控元件构建了酵母菌表达质粒pHX2,pHXA2和pHXC2。表达质粒分别转化酿酒酵母单倍体菌株YS58和以前通过细胞杂交构建的麦角甾醇高产菌株YEH56。通过营养缺陷互补和铜抗性筛选到转化子,质粒上的ARE2基因在YS58和YEH56中都实现了活性表达,使细胞内甾醇酯化水平升高,并导致细胞麦角甾醇含量的提高。对转化菌株的培养条件进行了初步研究,在优化条件下,重组转化菌株YEH56(pHX2)、YEH56(pHXA2)和YEH56(pHXC2)的麦角甾醇含量分别是受体菌YEH56 的13、13和14倍。     

CoQ10 deficiency diseases in adults

Deficiency of Coenzyme Q₁₀ (CoQ₁₀) in muscle has been associated with a spectrum of diseases including infantile-onset multi-systemic diseases, encephalomyopathies with recurrent myobinuria, cerebellar ataxia, and pure myopathy. CoQ₁₀ deficiency predominantly affects children, but patients have presented with adult-onset cerebellar ataxia or myopathy. Mutations in the CoQ10 biosynthetic genes, COQ2 and PDSS2, have been identified in children with the infantile form of CoQ₁₀ deficiency; however, the molecular genetic bases of adult-onset CoQ₁₀ deficiency remains undefined.     

磁胁迫对烟草细胞生长和CoQ10含量的影响

用0.4 T恒定磁场处理烟草细胞0.5～1.5 h后,细胞活力和存活率可受到一定的影响,但处理间差异不显著.处理0.5～1.0h的细胞分裂指数和细胞生物量显著提高,分别提高15.4%和49.6%,细胞干重分别提高18.4%和42.3%,但CoQ10的生物合成和积累受抑.处理1.5 h的细胞分裂和细胞生长受抑,但CoQ10的生物合成和积累得到促进,CoQ10含量提高25.2%.     

酵母发酵玉米秸秆水解液产麦角甾醇应用研究

生物质是一种可再生资源,生物质发酵可产生高端化工产品.本文主要探讨蒸汽爆破处理玉米秸秆及水解可发酵单糖,考察酵母发酵玉米秸秆糖化液产麦角甾醇的应用研究.实验结果表明:当固液比10%,盐酸浓度1.5%,90℃水解反应3 h,还原糖含量达到53.3%,纤维素转化率79%.发酵工艺参数为玉米秸秆糖化液6.0°Bx,玉米浆4%,pH 7.5,接种量10%,28℃摇床振荡培养32 h,细胞生物量达8.5 g/L,麦角甾醇含量可达2.35%.同时对玉米秸秆发酵产麦角甾醇晶体进行结构表征.